DxC 700 AU is an integrated solution comprising tools, insights, information management systems and continuous process improvements

Dubai - Beckman Coulter, a worldwide leader in developing clinical diagnostic products and solutions, launched its new DxC 700 AU chemistry analyzer in Dubai earlier today. Reducing the number of test-processing steps by 30 per cent, the analyzer streamlines workflow for laboratory professionals. This is the result of powerful operating software, an all-new design and an intuitive user-interface that allow operators to spend less time on daily tasks and more time producing the quality results that empower better decision-making for better patient care.

Dr. Phil Reavey , Clinical Biochemist delivered a presentation at the launch on how laboratories are currently struggling with results that are mostly pre-analytical in nature, outlining the various ways in which the lab can investigate such problems and more speedily identify the root cause. He outlined the major models for external quality assessment or proficiency testing.

Combining intuitive design of the DxC analyzer and the robust throughput of the AU analyzer – into one standardized platform, the device is designed to meet larger test volumes and reduces total cost of ownership for hospital laboratories and integrated delivery networks.

Dr. Phil Reavey said, “The healthcare sector could gain considerably by simplifying tasks for clinical laboratory professionals. The DxC 700 AU chemistry analyzer will enable laboratories to produce faster results and manage resources more efficiently.”

The DxC 700 AU analyzer reduces total cost of ownership by using fewer and longer lasting consumables compared to other industry same-class systems. The DxC 700 AU analyzer is part of Beckman Coulter's Total Laboratory Solution, featuring a broader comprehensive portfolio that provides the flexibility to tailor systems based on a laboratory's volume and space needs.

The DxC 700 AU analyzer is designed for mid-volume hospital laboratories and can serve smaller independent hospitals as well. It is also well-placed to be part of an integrated delivery network that could use a standardized chemistry solution for its entire group, and can connect to automation, immunoassay and clinical IT solutions.

-Ends-

© Press Release 2017